Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour

Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY Department of Urology, Indiana University Medical Center, Indianapolis, IN Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY, USA.
BJU International (Impact Factor: 3.53). 03/2012; 110(7):950-5. DOI: 10.1111/j.1464-410X.2012.10947.x
Source: PubMed


Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
The effect of advancing age on the clinicopathological outcomes of men with germ cell testicular cancers remains uncertain.
Through the review and comparison of the present large cohort of men with testis cancer, we report on our experience in men aged ≥50 years. Our results showed similar clinical and pathological characteristics, and survival outcomes that compare favourably with those of men aged <50 years.

27 Reads